18
Participants
Start Date
April 5, 2021
Primary Completion Date
December 4, 2024
Study Completion Date
December 4, 2024
Indocyanine green solution
Patients with clinical suspicion of necrotizing fasciitis would receive a weight-appropriate IV dose of indocyanine green (ICG, FDA-approved) with immediate fluorescence imaging of the affected body part and simultaneous imaging of an unaffected region
Dartmouth-Hitchock, Lebanon
Dartmouth-Hitchcock Medical Center
OTHER